Research
Energy balance
Tirzepatide was recently approved by the FDA for the management of type 2 diabetes.
Tirzepatide can be utilized in clinical settings for managing type 2 diabetes, with potential implications for weight loss.
StrongSupportsmedium confidence
Tirzepatide was recently approved by the Food and Drug Administration for the management of type 2 diabetes.
Why this rating
FDA approval is a high level of evidence regarding the drug's safety and efficacy.
Source
Tirzepatide for Weight Loss: Can Medical Therapy “Outweigh” Bariatric Surgery?
Joel Novograd et al. · Cardiology in Review · 2023
DOI 10.1097/crd.0000000000000515
reviewCited 10×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →